Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Jobst C. von Einem, Sylvia Peter, Christine Günther, Hans-Dieter Volk, Gerald Grütz, Christoph Salat, Oliver Stoetzer, Peter J. Nelson, Marlies Michl, Dominik P. Modest, Julian W. Holch, Martin Angele, Christiane Bruns, Hanno Niess, Volker Heinemann
Published Sep 16, 2017 · Vol. 8, No. 46 · pp. 80156-80166
Jia Zhou, Yixuan Zhao, Vera Simonenko, John J. Xu, Kai Liu, Deling Wang, Jingli Shi, Tianyi Zhong, Lixia Zhang, Lun Zeng, Bin Huang, Shenggao Tang, Alan Y. Lu, A. James Mixson, Yangbai Sun, Patrick Y. Lu, Qingfeng Li
Published Sep 14, 2017 · Vol. 8, No. 46 · pp. 80651-80665
Giles W. Robinson, Sue C. Kaste, Wassim Chemaitilly, Daniel C. Bowers, Stephen Laughton, Amy Smith, Nicholas Gottardo, Sonia Partap, Anne Bendel, Karen D. Wright, Brent A. Orr, William C. Warner, Arzu Onar-Thomas, Amar Gajjar
Published Sep 1, 2017 · Vol. 8, No. 41 · pp. 69295-69302